Visionnet Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 46.62%
- Profit Growth 182.75%
- Ebitda 30.79%
- Net Worth 24.39%
- Total Assets 25.72%
About Visionnet Pharmaceuticals
Visionnet Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2014 and has a history of Ten years and two months. Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Mhaske and Prakash Ghoderao serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24301PN2014PTC153171
-
Company No.
153171
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Visionnet Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Mhaske
|
Director | 20-Nov-2014 | Current |
|
Prakash Ghoderao
|
Director | 20-Nov-2014 | Current |
Financial Performance of Visionnet Pharmaceuticals.
Visionnet Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 46.62% increase. The company also saw a substantial improvement in profitability, with a 182.75% increase in profit. The company's net worth Soared by an impressive increase of 24.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Visionnet Pharmaceuticals?
In 2017, Visionnet Pharmaceuticals had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kk Pragat Farmers Producer Company LimitedRajendra Mhaske is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Visionnet Pharmaceuticals?
Unlock and access historical data on people associated with Visionnet Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Visionnet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Visionnet Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.